UA93269C2 - Mono-and divalent salts of n-(5-hydroxynicotinoil)-l-glutaminic acid exhibiting psychotropic (antidepressant, anxyolytic), neuroprotective, heroprotective and cerebroprotective action - Google Patents

Mono-and divalent salts of n-(5-hydroxynicotinoil)-l-glutaminic acid exhibiting psychotropic (antidepressant, anxyolytic), neuroprotective, heroprotective and cerebroprotective action

Info

Publication number
UA93269C2
UA93269C2 UAA200901767A UAA200901767A UA93269C2 UA 93269 C2 UA93269 C2 UA 93269C2 UA A200901767 A UAA200901767 A UA A200901767A UA A200901767 A UAA200901767 A UA A200901767A UA 93269 C2 UA93269 C2 UA 93269C2
Authority
UA
Ukraine
Prior art keywords
hydroxynicotinoil
heroprotective
anxyolytic
neuroprotective
antidepressant
Prior art date
Application number
UAA200901767A
Other languages
English (en)
Inventor
Павел Васильевич Якимук
Сергей Витальевич Стовбун
Александр Анатольевич Литвин
Original Assignee
Общество C Ограниченной Ответственностью "Национальная Исследовательская Компания"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39020154&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA93269(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Общество C Ограниченной Ответственностью "Национальная Исследовательская Компания" filed Critical Общество C Ограниченной Ответственностью "Национальная Исследовательская Компания"
Publication of UA93269C2 publication Critical patent/UA93269C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
UAA200901767A 2006-07-31 2007-06-06 Mono-and divalent salts of n-(5-hydroxynicotinoil)-l-glutaminic acid exhibiting psychotropic (antidepressant, anxyolytic), neuroprotective, heroprotective and cerebroprotective action UA93269C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006127564/04A RU2314293C1 (ru) 2006-07-31 2006-07-31 Одно- и двухвалентные соли n-(5-гидроксиникотиноил)-l-глутаминовой кислоты, обладающие психотропным (антидепрессивным и анксиолитическим), нейропротекторным, геропротекторным и противоинсультным действием

Publications (1)

Publication Number Publication Date
UA93269C2 true UA93269C2 (en) 2011-01-25

Family

ID=39020154

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200901767A UA93269C2 (en) 2006-07-31 2007-06-06 Mono-and divalent salts of n-(5-hydroxynicotinoil)-l-glutaminic acid exhibiting psychotropic (antidepressant, anxyolytic), neuroprotective, heroprotective and cerebroprotective action

Country Status (14)

Country Link
US (1) US8030493B2 (ru)
EP (1) EP2050737A4 (ru)
JP (1) JP2009545589A (ru)
KR (1) KR101439561B1 (ru)
CN (1) CN101500998B (ru)
AU (1) AU2007282178A1 (ru)
BR (1) BRPI0713814A8 (ru)
CA (1) CA2658589A1 (ru)
EA (1) EA014855B1 (ru)
MX (1) MX2009000400A (ru)
NZ (1) NZ574637A (ru)
RU (1) RU2314293C1 (ru)
UA (1) UA93269C2 (ru)
WO (1) WO2008018815A1 (ru)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1368314A1 (ru) * 1984-02-22 1988-01-23 Научно-исследовательский институт фармакологии АМН СССР @ -Никотиноиламинокислоты, обладающие противогипоксической и антиамнестической активностью
RU94038232A (ru) * 1994-10-10 1996-08-27 Научно-исследовательский институт фармакологии Томского научного центра РАМН Средство, улучшающее мозговое кровообращение

Also Published As

Publication number Publication date
KR20090037996A (ko) 2009-04-17
EA014855B1 (ru) 2011-02-28
US8030493B2 (en) 2011-10-04
EA200900274A1 (ru) 2009-06-30
RU2314293C1 (ru) 2008-01-10
BRPI0713814A8 (pt) 2018-01-09
CN101500998A (zh) 2009-08-05
KR101439561B1 (ko) 2014-09-11
EP2050737A4 (en) 2011-05-04
BRPI0713814A2 (pt) 2013-09-17
EP2050737A1 (en) 2009-04-22
CA2658589A1 (en) 2008-02-14
JP2009545589A (ja) 2009-12-24
WO2008018815A1 (fr) 2008-02-14
AU2007282178A1 (en) 2008-02-14
US20090240059A1 (en) 2009-09-24
MX2009000400A (es) 2009-03-02
CN101500998B (zh) 2011-06-01
NZ574637A (en) 2010-10-29

Similar Documents

Publication Publication Date Title
IL243287B (en) Crystalline form -ii- of 2-{4-[-n-(5,6-diphenylpyrazin-2-yl)--n-isopropylamino]butyloxy}-n-(methylsulfonyl)acetamide, pharmaceutical compositions containing it and its therapeutic uses
MX2007011023A (es) 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3.
MX2010006489A (es) Formas cristalinas de n-(terc-butoxicarbonil)-3-metil-l-valil-(4r) -4-((7-cloro-4-metoxi-1-isoquinolinil)oxi)-n-((1r,2s)-1-((ciclopr opilsulfonil)carbamoil)-2-vinilciclopropil)-l-prolinamida.
ZA201002848B (en) Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
MY151986A (en) Adamantyl diamide derivatives and uses of same
MY143249A (en) 4-substituted pyrrolidin-2-ones and their use
MX2010006143A (es) Azolilmetiloxiranos, su uso y agentes que lo contienen.
WO2007125103A3 (en) Benzamide glucokinase activators
ATE489371T1 (de) Benzamidglucokinaseaktivatoren
MX2010009536A (es) Amidas de acido 5-oxo-2,3,4,5-tetrahidro-benzo[b]oxepin-4-carboxil ico y amidas de acido 2,3-dihidro-benzo[b]oxepin-4-carboxilico para el tratamiento y la prevension de la diabetes tipo 1 y 2.
TW200738669A (en) Crystalline forms of N-(benzo[b]thien-3-ylmethyl)-sulfamide
DK2135861T4 (da) Fremgangsmåde til syntese af 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-on og dets anvendelse ved syntese af ivabradin såvel som dets additionssalte med en farmaceutisk acceptabel syre
ATE531703T1 (de) Benzochromenderivate
EA201071183A1 (ru) Безводная кристаллическая форма малеата орвепитанта
MX2009000767A (es) Sintesis de (2s,5r)-5-etinil-1-{n-(4-metil-1-(4-carboxi-piridin-2- il)piperidin-4-il)glicil}pirrolidina-2-carbonitrilo.
CL2009001436A1 (es) Compuestos cristalinos de (1r,2s,3r)-1-(2-isoxazol-3-il)-1himidazol-4-il)butano-1,2,3,4-tetraol; utiles en el tratamiento y/o prevencion de asma, esclerosis multiple, artritis reumatoide, entre otras enfermedades.
MX2013000433A (es) Sintesis de ciclopentaquinazolinas.
UA93269C2 (en) Mono-and divalent salts of n-(5-hydroxynicotinoil)-l-glutaminic acid exhibiting psychotropic (antidepressant, anxyolytic), neuroprotective, heroprotective and cerebroprotective action
IN2012DN00928A (ru)
BRPI0907664A2 (pt) ''composição farmacêutica anidra, uso de uma composição e processo de preparação de uma composição''
MX2009003106A (es) Nueva modificacion cristalina de 4-(n-metil-2-cloro-5-piridilmetil amino)-2,5-dihidrofuran-2-ona.
LV14346A (lv) 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetamīda 4R,5S-enantiomērs ar nootropo aktivitāti
WO2011034896A3 (en) Small molecule inhibitors of the alpha4-paxillin interaction
UA106192C2 (en) N-(1,1-dioxotetrahydrothiophen-3-yl)bicyclo[2.2.1]hept-5-ene-endo,endo-2,3- dicarboximide and n-(1,1-dioxotetrahydrothiophen-3-yl)-exo-5,6-epoxybicyclo-[2.2.1]heptane-endo,endo-2,3-dicarboximide exhibiting analgetic and anticonvulsant action
UA43867U (en) N-(1,1-dioxotetrahydrothiophene-3-yl)bicyclo[2.2.1]hept-5-ene-endo,endo-2,3-dicarboximide and n-(1,1- dioxotetrahydrothiophene-3-yl)-exo-5,6-epoxybicyclo[2.2.1]heptane-endo,endo-2,3-dicarboximide exhibiting analgetic and anticonvulsant action